According to the consensus-based updated 2010 Task Force Criteria, ARVC recognition is done by incorporating many pieces of information. [...] This trial aimed to investigate the prevalence of serious cardiovascular issues in...
Most Recent Articles
Dapagliflozin Effects on Patients With Cardiovascular Disorders
Regardless of ejection fraction, it is uncertain if the sodium-glucose cotransporter 2 inhibitor dapagliflozin lowers the chance of a variety of illnesses and death, resulting in patients having major cardiovascular illnesses.
VISUALIZED: Cardiac Assessments by Measuring Biomarkers to Evaluate Cardiac Pathology Among Individuals Infected With COVID-19
Read further: Cardiac Assessments by Measuring Biomarkers to Evaluate Cardiac Pathology Among Individuals Infected With COVID-19
Cardiac Assessments by Measuring Biomarkers to Evaluate Cardiac Pathology Among Individuals Infected With COVID-19
As many as 30% of people may experience unique, reoccurring, or persistent health issues for many weeks after having SARS-CoV-2.1 So-called protracted COVID may manifest in people with a wide range of initial symptoms, from...
Comparison of Recommendations for Statin Use for ASCVD Prevention
The guidelines of USPSTF provide recommendations for the use of statin therapy for the prevention of atherosclerotic cardiovascular disease (ASCVD) for adults of 40-75 years of age with equal or greater than 1 CVD risk factor...